Latest Insider Transactions at Prothena Corp Public LTD CO (PRTA)
This section provides a real-time view of insider transactions for Prothena Corp Public LTD CO (PRTA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of PROTHENA CORP PUBLIC LTD CO to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of PROTHENA CORP PUBLIC LTD CO's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 19
2022
|
Tran Nguyen Chief Strategy Officer and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+43.1%
|
$60,000
$6.73 P/Share
|
|
Oct 10
2022
|
Shane Cooke |
SELL
Open market or private sale
|
Direct |
5,000
-73.24%
|
$275,000
$55.88 P/Share
|
|
Oct 10
2022
|
Shane Cooke |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$30,000
$6.41 P/Share
|
|
Oct 05
2022
|
Richard T Collier |
SELL
Open market or private sale
|
Direct |
5,000
-29.74%
|
$290,000
$58.35 P/Share
|
|
Oct 05
2022
|
Richard T Collier |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+44.57%
|
$30,000
$6.41 P/Share
|
|
Oct 03
2022
|
Hideki Garren Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
4,000
-100.0%
|
$240,000
$60.9 P/Share
|
|
Oct 03
2022
|
Hideki Garren Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+50.0%
|
$96,000
$24.9 P/Share
|
|
Oct 03
2022
|
Lars Ekman |
SELL
Open market or private sale
|
Direct |
15,833
-54.99%
|
$965,813
$61.61 P/Share
|
|
Oct 03
2022
|
Lars Ekman |
BUY
Exercise of conversion of derivative security
|
Direct |
15,833
+49.62%
|
$94,998
$6.41 P/Share
|
|
Sep 28
2022
|
Gene G. Kinney President and CEO |
SELL
Open market or private sale
|
Direct |
16,412
-7.47%
|
$869,836
$53.72 P/Share
|
|
Sep 28
2022
|
Gene G. Kinney President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
16,412
+35.98%
|
$98,472
$6.41 P/Share
|
|
Sep 28
2022
|
Lars Ekman |
SELL
Open market or private sale
|
Direct |
31,666
-99.24%
|
$1,519,968
$48.09 P/Share
|
|
Sep 28
2022
|
Lars Ekman |
BUY
Exercise of conversion of derivative security
|
Direct |
31,666
+49.81%
|
$189,996
$6.41 P/Share
|
|
Sep 28
2022
|
Shane Cooke |
SELL
Open market or private sale
|
Direct |
10,000
-100.0%
|
$480,000
$48.09 P/Share
|
|
Sep 28
2022
|
Shane Cooke |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+50.0%
|
$60,000
$6.41 P/Share
|
|
Sep 28
2022
|
Richard T Collier |
SELL
Open market or private sale
|
Direct |
25,000
-95.35%
|
$1,200,000
$48.09 P/Share
|
|
Sep 28
2022
|
Richard T Collier |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+48.81%
|
$150,000
$6.41 P/Share
|
|
Sep 21
2022
|
Tran Nguyen Chief Strategy Officer and CFO |
SELL
Open market or private sale
|
Direct |
10,000
-75.76%
|
$300,000
$30.75 P/Share
|
|
Sep 21
2022
|
Tran Nguyen Chief Strategy Officer and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+43.1%
|
$60,000
$6.73 P/Share
|
|
Sep 21
2022
|
Gene G. Kinney President and CEO |
SELL
Open market or private sale
|
Direct |
2,720
-17.53%
|
$87,040
$32.02 P/Share
|
|
Sep 21
2022
|
Gene G. Kinney President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,720
+14.92%
|
$16,320
$6.41 P/Share
|
|
Sep 15
2022
|
Hideki Garren Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
4,000
-100.0%
|
$120,000
$30.0 P/Share
|
|
Sep 15
2022
|
Hideki Garren Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+50.0%
|
$96,000
$24.9 P/Share
|
|
Aug 24
2022
|
Tran Nguyen Chief Strategy Officer and CFO |
SELL
Open market or private sale
|
Direct |
10,000
-75.76%
|
$300,000
$30.17 P/Share
|
|
Aug 24
2022
|
Tran Nguyen Chief Strategy Officer and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+43.1%
|
$60,000
$6.73 P/Share
|
|
Aug 17
2022
|
Gene G. Kinney President and CEO |
SELL
Open market or private sale
|
Direct |
2,181
-14.57%
|
$69,792
$32.03 P/Share
|
|
Aug 17
2022
|
Gene G. Kinney President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,181
+12.71%
|
$13,086
$6.41 P/Share
|
|
Aug 12
2022
|
Gene G. Kinney President and CEO |
SELL
Open market or private sale
|
Direct |
20,284
-61.32%
|
$649,088
$32.16 P/Share
|
|
Aug 12
2022
|
Gene G. Kinney President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
20,284
+38.01%
|
$121,704
$6.41 P/Share
|
|
Aug 11
2022
|
Gene G. Kinney President and CEO |
SELL
Open market or private sale
|
Direct |
13,650
-51.62%
|
$436,800
$32.16 P/Share
|
|
Aug 11
2022
|
Gene G. Kinney President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
13,650
+34.05%
|
$81,900
$6.41 P/Share
|
|
Aug 10
2022
|
Gene G. Kinney President and CEO |
SELL
Open market or private sale
|
Direct |
991
-7.19%
|
$31,712
$32.01 P/Share
|
|
Aug 10
2022
|
Gene G. Kinney President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
991
+6.71%
|
$5,946
$6.41 P/Share
|
|
Aug 05
2022
|
Gene G. Kinney President and CEO |
SELL
Open market or private sale
|
Direct |
21,506
-37.92%
|
$688,192
$32.92 P/Share
|
|
Aug 05
2022
|
Gene G. Kinney President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
21,506
+38.54%
|
$129,036
$6.41 P/Share
|
|
Aug 04
2022
|
Gene G. Kinney President and CEO |
SELL
Open market or private sale
|
Direct |
20,954
-62.09%
|
$670,528
$32.18 P/Share
|
|
Aug 04
2022
|
Gene G. Kinney President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
20,954
+38.31%
|
$125,724
$6.41 P/Share
|
|
Aug 01
2022
|
Hideki Garren Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
4,000
-100.0%
|
$120,000
$30.52 P/Share
|
|
Aug 01
2022
|
Hideki Garren Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+50.0%
|
$96,000
$24.9 P/Share
|
|
Jul 27
2022
|
Gene G. Kinney President and CEO |
SELL
Open market or private sale
|
Direct |
376
-2.86%
|
$12,032
$32.0 P/Share
|
|
Jul 27
2022
|
Gene G. Kinney President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
376
+2.78%
|
$2,256
$6.41 P/Share
|
|
Jul 22
2022
|
Tran Nguyen Chief Strategy Officer and CFO |
SELL
Open market or private sale
|
Direct |
7,320
-69.58%
|
$234,240
$32.55 P/Share
|
|
Jul 22
2022
|
Tran Nguyen Chief Strategy Officer and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
7,320
+41.03%
|
$43,920
$6.73 P/Share
|
|
Jul 21
2022
|
Tran Nguyen Chief Strategy Officer and CFO |
SELL
Open market or private sale
|
Direct |
20,560
-43.33%
|
$678,480
$33.16 P/Share
|
|
Jul 21
2022
|
Tran Nguyen Chief Strategy Officer and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
20,560
+46.39%
|
$123,360
$6.73 P/Share
|
|
Jul 20
2022
|
Shane Cooke |
SELL
Open market or private sale
|
Direct |
15,000
-100.0%
|
$480,000
$32.9 P/Share
|
|
Jul 20
2022
|
Shane Cooke |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+50.0%
|
$90,000
$6.41 P/Share
|
|
Jul 20
2022
|
Tran Nguyen Chief Strategy Officer and CFO |
SELL
Open market or private sale
|
Direct |
42,120
-69.8%
|
$1,347,840
$32.53 P/Share
|
|
Jul 20
2022
|
Tran Nguyen Chief Strategy Officer and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
42,120
+48.17%
|
$252,720
$6.73 P/Share
|
|
Jul 06
2022
|
Hideki Garren Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
8,000
-100.0%
|
$240,000
$30.0 P/Share
|